Back to Search
Start Over
CPX-351 for higher risk myelodysplastic syndrome: cytarabine and daunorubicin in disguise?
- Source :
-
The Lancet. Haematology [Lancet Haematol] 2023 Jul; Vol. 10 (7), pp. e481-e482. Date of Electronic Publication: 2023 May 25. - Publication Year :
- 2023
-
Abstract
- Competing Interests: We declare no competing interests.
Details
- Language :
- English
- ISSN :
- 2352-3026
- Volume :
- 10
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- The Lancet. Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 37245521
- Full Text :
- https://doi.org/10.1016/S2352-3026(23)00153-9